About Parth Biocare Private Limited
Data last updated:
Parth Biocare Private Limited is a private limited company based in Bhilai, Chhattisgarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U24232CT2010PTC022210.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Utkarsh Kumar Verma and Meena Ramrup Vishwakarma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 6 & 7 Street 13 Ashish Nagar West, Bhilai, Chhattisgarh, India – 490006.
As per the financials filed for FY 2025, the company reported a revenue of ₹16,690, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹7,910 (net margin 47.4%) and EBITDA of ₹10,690 (EBITDA margin 64.1%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years.
The company is associated with 1 brand: Parth Biocare.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website parthbiocare.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressD – 6 & 7 Street 13 Ashish Nagar West, Bhilai, Chhattisgarh, India – 490006
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Parth Biocare Private Limited
Parth Biocare operates one associated brand: Parth Biocare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Trading and contract manufacturing of pharmaceutical and nutraceutical products. | parthbiocare.com |
Financials of Parth Biocare Private Limited FY 2025 filings available
Parth Biocare Private Limited reported revenue of ₹16,690 (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Parth Biocare Private Limited
Revenue rose 7% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 18%. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Parth Biocare Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10,690 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7,910 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Parth Biocare Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 64.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 47.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Parth Biocare are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Parth Biocare Private Limited
Parth Biocare has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Utkarsh Kumar Verma Also directs: Zeon Pharma Industries (India) Private Limited | Director | 13 Dec 2010 | 15 Years 10 Months | Current |
| Meena Ramrup Vishwakarma | Director | 25 Dec 2010 | 15 Years 9 Months | Current |
| Rani Verma | Director | 13 Dec 2010 | 15 Years 10 Months | Current |
Peer Comparison of Parth Biocare Private Limited
Parth Biocare Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| International Center for Nanodevices Private Limited | ₹21,088 (FY 2025) | •••• | •••• | -98.0% | •••• | Bangalore, Karnataka, India |
| Bijam Biosciences Private Limited | ₹21,000 (FY 2022) | •••• | •••• | -73.0% | •••• | Hyderabad, Telangana, India |
| Greyfast Technology Private Limited | ₹19,620 (FY 2025) | •••• | •••• | -24.0% | •••• | Navi Mumbai, Maharashtra, India |
| Amthera Life Sciences Private Limited | ₹18,360 (FY 2025) | •••• | •••• | -23.0% | •••• | Bangalore, Second Floor, Karnataka, India |
| Avestagenome Project International Private Limited | ₹16,997 (FY 2022) | •••• | •••• | •••• | Bgnorth, Karnataka, India | |
| Parth Biocare Private Limited this company | ₹16,690 (FY 2025) | •••• | •••• | 7.0% | •••• | Bhilai, Chhattisgarh, India |
| Procell Biologics Private Limited | ₹14,740 (FY 2025) | •••• | •••• | -99.0% | •••• | Medchal Malkajgiri, Telangana, India |
| Council for Healthcare and Pharma Front | ₹13,829 (FY 2025) | •••• | •••• | 400.0% | •••• | New Delhi, Delhi, India |
| Kis Technologies (India) Private Limited | ₹13,544 (FY 2018) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Mercuri Biotechnologies Private Limited | ₹13,125 (FY 2021) | •••• | •••• | -99.0% | •••• | Bangalore, Karnataka, India |
| Extremz Biosciences Private Limited | ₹13,049 (FY 2022) | •••• | •••• | -95.0% | •••• | Hubli, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Parth Biocare by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Parth Biocare Private Limited
Parth Biocare Private Limited is audited by JAIN CHINDALIA & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAIN CHINDALIA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Parth Biocare Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Parth Biocare Private Limited
Parth Biocare Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Parth Biocare Private Limited
Employment history and EPFO contributions of people linked to Parth Biocare.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Parth Biocare Private Limited
Parth Biocare Private Limited has 3 board changes on record since 2010: 3 appointments. The latest: Meena Ramrup Vishwakarma was appointed as Director on 25 Dec 2010.
Credit Ratings, Litigation & Regulatory Alerts for Parth Biocare Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Parth Biocare Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Parth Biocare Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Parth Biocare Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Parth Biocare Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parth Biocare Private Limited
Parth Biocare is an active private limited company based in Bhilai, Chhattisgarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 December 2010 (16+ years old) and is registered under CIN U24232CT2010PTC022210.
Parth Biocare reported revenue of ₹16,690 for FY 2025 (up 7% YoY).
Parth Biocare has 3 current directors:
- Utkarsh Kumar Verma - Director
- Meena Ramrup Vishwakarma - Director
- Rani Verma - Director
Parth Biocare reported a net profit of ₹7,910 (net margin 47.4%) and EBITDA of ₹10,690 (EBITDA margin 64.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Parth Biocare is -18% over three years. In the latest year (FY 2025) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Parth Biocare is U24232CT2010PTC022210. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parth Biocare was incorporated on 13 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of Parth Biocare by revenue are International Center for Nanodevices Private Limited, Bijam Biosciences Private Limited, Greyfast Technology Private Limited, Amthera Life Sciences Private Limited, Avestagenome Project International Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Meena Ramrup Vishwakarma was appointed as Director on 25 Dec 2010. Rani Verma was appointed as Director on 13 Dec 2010. Utkarsh Kumar Verma was appointed as Director on 13 Dec 2010.
Parth Biocare can be reached through the website parthbiocare.com. Its registered office is in Bhilai, Chhattisgarh, India.
The registered office of Parth Biocare is at D – 6 & 7 Street 13 Ashish Nagar West, Bhilai, Chhattisgarh, India – 490006.